| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.34▼ | 1.34▲ | 1.34▲ | 1.51▼ | 1.57▼ |
| MA10 | 1.34▲ | 1.34▲ | 1.39▼ | 1.57▼ | 1.50▼ |
| MA20 | 1.33▲ | 1.40▼ | 1.47▼ | 1.56▼ | 1.38▼ |
| MA50 | 1.34▲ | 1.51▼ | 1.55▼ | 1.50▼ | 0.82▲ |
| MA100 | 1.40▼ | 1.56▼ | 1.60▼ | 1.31▲ | 1.40▼ |
| MA200 | 1.49▼ | 1.60▼ | 1.47▼ | 0.84▲ | 2.08▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.001▲ | -0.015▼ | -0.027▼ | -0.017▼ |
| RSI | 50.808▲ | 30.434▼ | 21.146▼ | 39.361▼ | 52.808▲ |
| STOCH | 58.333 | 51.266 | 26.478 | 29.659 | 47.581 |
| WILL %R | -50.000 | -65.957 | -78.947▼ | -85.712▼ | -75.281▼ |
| CCI | 51.220 | -17.413 | -64.548 | -278.996▼ | -46.368 |
|
Thursday, December 18, 2025 05:34 AM
OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral direct activator, OV4071There were no treatment-related laboratory findings, no ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/12/25 | 1.35 | 1.445 | 1.26 | 1.34 | 2,868,925 |
| 17/12/25 | 1.55 | 1.644 | 1.47 | 1.48 | 846,076 |
| 16/12/25 | 1.53 | 1.62 | 1.53 | 1.55 | 757,650 |
| 15/12/25 | 1.63 | 1.64 | 1.55 | 1.56 | 1,007,180 |
| 12/12/25 | 1.69 | 1.71 | 1.61 | 1.64 | 886,131 |
| 11/12/25 | 1.62 | 1.68 | 1.575 | 1.65 | 1,416,805 |
| 10/12/25 | 1.58 | 1.63 | 1.54 | 1.62 | 1,412,725 |
| 09/12/25 | 1.61 | 1.65 | 1.565 | 1.57 | 1,603,894 |
| 08/12/25 | 1.68 | 1.69 | 1.565 | 1.58 | 1,670,758 |
| 05/12/25 | 1.64 | 1.745 | 1.6296 | 1.67 | 1,408,277 |
|
|
||||
|
|
||||
|
|